Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income Statement
Earnings Waterfall
Vertex Pharmaceuticals Inc
Revenue
|
9.9B
USD
|
Cost of Revenue
|
-1.3B
USD
|
Gross Profit
|
8.6B
USD
|
Operating Expenses
|
-4.8B
USD
|
Operating Income
|
3.8B
USD
|
Other Expenses
|
-212.4m
USD
|
Net Income
|
3.6B
USD
|
Income Statement
Vertex Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 212
N/A
|
1 002
-17%
|
830
-17%
|
787
-5%
|
580
-26%
|
601
+3%
|
628
+5%
|
759
+21%
|
1 032
+36%
|
1 292
+25%
|
1 557
+21%
|
1 661
+7%
|
1 702
+2%
|
2 019
+19%
|
2 131
+6%
|
2 296
+8%
|
2 489
+8%
|
2 415
-3%
|
2 623
+9%
|
2 829
+8%
|
3 048
+8%
|
3 265
+7%
|
3 454
+6%
|
3 620
+5%
|
4 163
+15%
|
4 820
+16%
|
5 403
+12%
|
5 991
+11%
|
6 206
+4%
|
6 415
+3%
|
6 684
+4%
|
7 130
+7%
|
7 574
+6%
|
7 948
+5%
|
8 351
+5%
|
8 701
+4%
|
8 931
+3%
|
9 208
+3%
|
9 505
+3%
|
9 654
+2%
|
9 869
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(130)
|
(103)
|
(82)
|
(69)
|
(40)
|
(58)
|
(57)
|
(75)
|
(117)
|
(163)
|
(191)
|
(213)
|
(207)
|
(207)
|
(233)
|
(252)
|
(273)
|
(300)
|
(333)
|
(371)
|
(410)
|
(433)
|
(464)
|
(485)
|
(548)
|
(615)
|
(664)
|
(718)
|
(736)
|
(766)
|
(810)
|
(860)
|
(904)
|
(958)
|
(992)
|
(1 044)
|
(1 080)
|
(1 101)
|
(1 148)
|
(1 178)
|
(1 262)
|
|
Gross Profit |
1 082
N/A
|
899
-17%
|
747
-17%
|
718
-4%
|
541
-25%
|
543
+0%
|
571
+5%
|
684
+20%
|
915
+34%
|
1 129
+23%
|
1 366
+21%
|
1 448
+6%
|
1 495
+3%
|
1 812
+21%
|
1 899
+5%
|
2 044
+8%
|
2 216
+8%
|
2 115
-5%
|
2 290
+8%
|
2 458
+7%
|
2 638
+7%
|
2 832
+7%
|
2 990
+6%
|
3 135
+5%
|
3 615
+15%
|
4 204
+16%
|
4 739
+13%
|
5 273
+11%
|
5 469
+4%
|
5 649
+3%
|
5 874
+4%
|
6 270
+7%
|
6 670
+6%
|
6 990
+5%
|
7 359
+5%
|
7 656
+4%
|
7 850
+3%
|
8 107
+3%
|
8 357
+3%
|
8 477
+1%
|
8 607
+2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1 238)
|
(1 240)
|
(1 232)
|
(1 192)
|
(1 182)
|
(1 150)
|
(1 166)
|
(1 246)
|
(1 380)
|
(1 432)
|
(1 497)
|
(1 529)
|
(1 484)
|
(1 506)
|
(1 540)
|
(1 738)
|
(1 823)
|
(1 874)
|
(1 932)
|
(1 824)
|
(1 974)
|
(2 020)
|
(2 081)
|
(2 332)
|
(2 418)
|
(2 563)
|
(2 650)
|
(2 611)
|
(2 613)
|
(2 625)
|
(3 606)
|
(3 620)
|
(3 888)
|
(4 055)
|
(3 267)
|
(3 492)
|
(3 530)
|
(4 061)
|
(4 391)
|
(4 600)
|
(4 775)
|
|
Selling, General & Administrative |
(356)
|
(338)
|
(311)
|
(300)
|
(305)
|
(317)
|
(334)
|
(359)
|
(377)
|
(396)
|
(413)
|
(420)
|
(433)
|
(441)
|
(457)
|
(471)
|
(496)
|
(513)
|
(523)
|
(539)
|
(558)
|
(575)
|
(594)
|
(616)
|
(659)
|
(694)
|
(729)
|
(754)
|
(771)
|
(780)
|
(783)
|
(797)
|
(840)
|
(863)
|
(884)
|
(933)
|
(945)
|
(971)
|
(1 018)
|
(1 035)
|
(1 137)
|
|
Research & Development |
(882)
|
(903)
|
(921)
|
(893)
|
(856)
|
(833)
|
(832)
|
(887)
|
(996)
|
(1 036)
|
(1 083)
|
(1 110)
|
(1 048)
|
(1 066)
|
(1 084)
|
(1 267)
|
(1 325)
|
(1 362)
|
(1 410)
|
(1 285)
|
(1 417)
|
(1 445)
|
(1 487)
|
(1 712)
|
(1 755)
|
(1 864)
|
(1 905)
|
(1 843)
|
(1 830)
|
(1 837)
|
(2 823)
|
(2 824)
|
(3 051)
|
(3 198)
|
(2 440)
|
(2 620)
|
(2 643)
|
(3 129)
|
(3 377)
|
(3 564)
|
(3 690)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(5)
|
(6)
|
(15)
|
(14)
|
(13)
|
(8)
|
0
|
1
|
3
|
7
|
58
|
61
|
58
|
39
|
3
|
(1)
|
52
|
|
Operating Income |
(157)
N/A
|
(341)
-118%
|
(485)
-42%
|
(475)
+2%
|
(642)
-35%
|
(607)
+5%
|
(595)
+2%
|
(562)
+6%
|
(465)
+17%
|
(303)
+35%
|
(130)
+57%
|
(81)
+38%
|
11
N/A
|
306
+2 629%
|
358
+17%
|
307
-14%
|
393
+28%
|
241
-39%
|
358
+49%
|
633
+77%
|
664
+5%
|
812
+22%
|
909
+12%
|
803
-12%
|
1 198
+49%
|
1 641
+37%
|
2 089
+27%
|
2 662
+27%
|
2 856
+7%
|
3 024
+6%
|
2 268
-25%
|
2 650
+17%
|
2 782
+5%
|
2 935
+5%
|
4 092
+39%
|
4 165
+2%
|
4 320
+4%
|
4 046
-6%
|
3 966
-2%
|
3 877
-2%
|
3 832
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(23)
|
(35)
|
(44)
|
(65)
|
(73)
|
(79)
|
(84)
|
(85)
|
(84)
|
(84)
|
(83)
|
(82)
|
(81)
|
(78)
|
(72)
|
(66)
|
(58)
|
(50)
|
(50)
|
(44)
|
(34)
|
(20)
|
(4)
|
(2)
|
10
|
(20)
|
54
|
119
|
100
|
88
|
9
|
(18)
|
(40)
|
(62)
|
(146)
|
(130)
|
(59)
|
147
|
378
|
480
|
563
|
|
Non-Reccuring Items |
(453)
|
(47)
|
(46)
|
(74)
|
(14)
|
(41)
|
(44)
|
(5)
|
(2)
|
(6)
|
(4)
|
(3)
|
(1)
|
(11)
|
(14)
|
(269)
|
(270)
|
(260)
|
(256)
|
(0)
|
(29)
|
(29)
|
(29)
|
(29)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(13)
|
(13)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
7
|
9
|
47
|
38
|
(6)
|
25
|
(12)
|
(9)
|
(7)
|
3
|
0
|
1
|
4
|
(1)
|
(2)
|
(80)
|
(81)
|
15
|
75
|
91
|
(1)
|
(57)
|
(60)
|
(21)
|
187
|
111
|
87
|
125
|
160
|
168
|
135
|
116
|
(12)
|
(9)
|
(0)
|
4
|
(16)
|
(24)
|
(37)
|
(48)
|
(15)
|
|
Pre-Tax Income |
(626)
N/A
|
(414)
+34%
|
(528)
-27%
|
(576)
-9%
|
(735)
-28%
|
(702)
+4%
|
(735)
-5%
|
(660)
+10%
|
(558)
+16%
|
(390)
+30%
|
(217)
+44%
|
(164)
+25%
|
(67)
+59%
|
217
N/A
|
270
+25%
|
(108)
N/A
|
(16)
+85%
|
(55)
-248%
|
126
N/A
|
680
+438%
|
600
-12%
|
706
+18%
|
816
+16%
|
751
-8%
|
1 395
+86%
|
1 732
+24%
|
2 230
+29%
|
2 905
+30%
|
3 117
+7%
|
3 280
+5%
|
2 411
-26%
|
2 748
+14%
|
2 730
-1%
|
2 864
+5%
|
3 933
+37%
|
4 027
+2%
|
4 232
+5%
|
4 169
-1%
|
4 306
+3%
|
4 309
+0%
|
4 380
+2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
122
|
(9)
|
(6)
|
(6)
|
(7)
|
(6)
|
(36)
|
(34)
|
(30)
|
(36)
|
(24)
|
(23)
|
(17)
|
(15)
|
(1)
|
125
|
107
|
124
|
118
|
(16)
|
(73)
|
(137)
|
(187)
|
(192)
|
(218)
|
(221)
|
(149)
|
(214)
|
(405)
|
(518)
|
(419)
|
(572)
|
(388)
|
(413)
|
(738)
|
(753)
|
(910)
|
(909)
|
(941)
|
(839)
|
(760)
|
|
Income from Continuing Operations |
(504)
|
(423)
|
(534)
|
(582)
|
(742)
|
(708)
|
(770)
|
(694)
|
(588)
|
(426)
|
(241)
|
(187)
|
(84)
|
202
|
269
|
17
|
92
|
69
|
245
|
664
|
527
|
569
|
630
|
559
|
1 177
|
1 511
|
2 081
|
2 691
|
2 712
|
2 762
|
1 992
|
2 176
|
2 342
|
2 451
|
3 195
|
3 273
|
3 322
|
3 260
|
3 365
|
3 470
|
3 620
|
|
Income to Minority Interest |
5
|
0
|
0
|
0
|
4
|
4
|
36
|
35
|
32
|
26
|
(34)
|
(32)
|
(28)
|
(24)
|
(9)
|
179
|
172
|
157
|
171
|
(17)
|
10
|
27
|
26
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(445)
N/A
|
(370)
+17%
|
(472)
-28%
|
(518)
-10%
|
(739)
-43%
|
(705)
+5%
|
(734)
-4%
|
(659)
+10%
|
(556)
+16%
|
(399)
+28%
|
(275)
+31%
|
(219)
+20%
|
(112)
+49%
|
177
N/A
|
260
+46%
|
196
-25%
|
263
+35%
|
226
-14%
|
415
+84%
|
647
+56%
|
2 096
+224%
|
2 155
+3%
|
2 215
+3%
|
2 144
-3%
|
1 177
-45%
|
1 511
+28%
|
2 081
+38%
|
2 691
+29%
|
2 712
+1%
|
2 762
+2%
|
1 992
-28%
|
2 176
+9%
|
2 342
+8%
|
2 451
+5%
|
3 195
+30%
|
3 273
+2%
|
3 322
+1%
|
3 260
-2%
|
3 365
+3%
|
3 470
+3%
|
3 620
+4%
|
|
EPS (Diluted) |
-1.92
N/A
|
-1.58
+18%
|
-2.01
-27%
|
-2.19
-9%
|
-3.13
-43%
|
-2.94
+6%
|
-3.04
-3%
|
-2.74
+10%
|
-2.31
+16%
|
-1.64
+29%
|
-1.12
+32%
|
-0.89
+21%
|
-0.46
+48%
|
0.71
N/A
|
1.03
+45%
|
0.78
-24%
|
1.04
+33%
|
0.87
-16%
|
1.59
+83%
|
2.5
+57%
|
8.08
+223%
|
8.28
+2%
|
8.52
+3%
|
8.22
-4%
|
4.51
-45%
|
5.73
+27%
|
7.91
+38%
|
10.18
+29%
|
10.29
+1%
|
10.54
+2%
|
7.63
-28%
|
8.37
+10%
|
9.01
+8%
|
9.5
+5%
|
12.34
+30%
|
12.61
+2%
|
12.82
+2%
|
12.52
-2%
|
12.92
+3%
|
13.33
+3%
|
13.89
+4%
|